Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Pacific Biosciences of California Inc. logo

Pacific Biosciences of California Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

3.17
 
USD
  
-0.21
  
(-6.21%)
Optionable: Yes  Market Cap: 967 M  90-day average vol: 8,238,196

Previous close: 3.38  Open: 3.31  Bid: 3.17  Ask: 3.19
52 week range    
3.13   
   14.55
Peers   
ILMN / 
NSTG / 
PKI / 
TMO / 
FLDM / 
Last updated: Monday 15th April 2024
44
MarketXLS Rank
60
Value
38
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

FLDM

0 B-3.63.46

GE

0.0032108 B-15.299.9

ILMN

56 B57.3355.92

NSTG

2 B-14.336.25

PKI

0.001522 B17.1182.49

TMO

0.0017234 B27587.05
Financials

PACB Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AcquisitionExpense31 M
Amortization of intangibles410 M410 M
Basic EPS from continuing operations-0.02-0.550.18-0.89-1.4
Basic EPS total-0.550.18-0.89-1.4
Basic weighted shares outstanding63 M70 M76 M89 M106 M135 M153 M165 M204 M225 M
Cost of sales-16 M-30 M-31 M-35 M-59 M-54 M56 M46 M72 M79 M
Depreciation-6 M-4 M-4 M-4 M-8 M-7 M7 M6 M7 M9 M
Depreciation unreconciled306000.0
DepreciationAndAmortization-6 M-4 M-4 M-4 M-8 M-7 M7 M6 M306000.09 M
Diluted EPS total-1.26-0.94-0.42-0.83-0.87-0.76-0.550.17-0.89-1.4
Diluted normalized net income/share-0.020.17-0.89-1.4
Diluted weighted shares outstanding63 M70 M78 M90 M106 M135 M175 M204 M225 M
GainOnSaleOfSecurity-418000.0395000.0-344000.0-244000.0
GeneralAndAdministrativeExpense-2 M-2 M-1 M-200000.0-6 M-6 M75 M73 M124 M161 M
Gross operating profit6 M23 M53 M44 M35 M25 M35 M33 M59 M49 M
Income before tax-79 M-66 M-32 M-74 M-92 M-103 M-84 M29 M-275 M-314 M
Income taxes-113 M-94 M
InterestExpenseNonOperating2 M3 M3 M3 M3 M2 M3 M267000.013 M15 M
MiscOtherSpecialCharges728000.0-478000.0364000.0103000.094 M79 M19 M36 M-52 M8 M
Net income from total operations-79 M-66 M-32 M-74 M-92 M-103 M-84 M29 M-181 M-314 M
NetIncomeCommonStockholders-79 M-66 M-32 M-74 M-92 M-103 M-84 M-69 M-181 M-314 M
NetIncomeContinuousOperations-79 M-66 M-32 M-74 M-92 M-103 M-84 M29 M-181 M-314 M
NetIncomeFromOtherGainsLosses98 M
NetNonOperatingInterestIncomeExpense-2 M-3 M-3 M-3 M-3 M-2 M-3 M-267000.0-13 M-15 M
Normalized income-336 M-245 M
Operating income-78 M-63 M-29 M-71 M-183 M-180 M-101 M-104 M-210 M-307 M
Operating income before depreciation (EBITDA)-71 M-58 M-24 M-66 M-80 M-92 M-70 M39 M-250 M-282 M
OperatingExpense-84 M-86 M-83 M-115 M-124 M-126 M135 M137 M269 M356 M
Other income net-728000.0478000.0-364000.0-103000.0-94 M-79 M-19 M-36 M53 M-5 M
OtherGandA-2 M-2 M-1 M-200000.0-6 M-6 M75 M73 M124 M161 M
OtherOperatingExpenses-84 M-86 M-23 M-115 M-124 M-126 M-2 M-1 M-2 M-2 M
OtherWriteOff733000.0
RentAndLandingFees-2 M-2 M-1 M-200000.0-6 M-6 M-7 M-7 M-8 M-11 M
Research & development expense45 M48 M60 M68 M65 M63 M60 M64 M113 M193 M
ResearchExpense45 M48 M60 M68 M65 M63 M60 M64 M113 M193 M
Revenue per share306000.0411 M
SalariesAndWages-10 M-10 M-14 M-20 M-20 M-23 M16 M300000.0900000.0700000.0
Selling Gen & administrative expense39 M38 M45 M48 M59 M63 M75 M73 M124 M161 M
SellingAndMarketingExpense39 M38 M45 M48 M59 M63 M
SellingExpense39 M38 M45 M48 M59 M63 M
Total Income available for interest expense (EBIT)-77 M-63 M-29 M-71 M-89 M-100 M-82 M30 M-262 M-300 M
Total common shares outstanding70 M75 M86 M93 M131 M151 M153 M193 M221 M247 M
Total net income-79 M-66 M-32 M-74 M-92 M-103 M-84 M29 M-181 M-314 M
Total ordinary shares268 M268 M268 M268 M268 M268 M268 M268 M268 M268 M
Total revenues28 M61 M93 M91 M93 M79 M91 M79 M131 M128 M
TotalExpenses-100 M-116 M-113 M-150 M-183 M-180 M191 M183 M341 M436 M
TotalRevenue20 M35 M38 M65 M93 M79 M91 M79 M131 M128 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University